期刊文献+

静脉注射用胰岛素三嵌段共聚物纳米粒的制备 被引量:4

Preparation of insulin-loaded triblock copolymeric nanoparticle drug delivery system for intravenous injection
下载PDF
导出
摘要 目的研究静脉注射用胰岛素三嵌段共聚物纳米粒(Ins-PELGE-NPs)的制备工艺,并考察其影响因素。方法通过复SL/溶剂扩散法制备Ins-PELGE-NPs,并考察其形态、粒径分布、包封率、zeta电位等。结果载药量为4.48%~4.67%的Ins-PELGE-NPs在透射电镜下均呈球形或近球形,分布均匀,平均粒径为140nm,平均包封率为94%~98%,平均zeta电位为-21.7±4.3mV。结论所用制备工艺简单、包封率高,可用于系列注射用三嵌段共聚物纳米粒的制备。 OBJECTIVE To study the preparation of insulin - loaded triblock copolymeric nanoparticles ( Ins - PELGE - NPs) and their influence factors on the characteristics of Ins - PELGE - NPs. METHODS The Ins - PELGE - NPs were prepared using a water - in - oil - in - water ( W1/O/W2 ) emulsion solvent diffusion technique. The characteristics of the nanoparticles were studied in terms of morphology, particle size distribution, encapsulation efficiency (EE) and zeta potential. RESULTS The Ins - PELGE - NPs with insulin loading of 4.48% -4.67% in transmission electron microscopy (TEM) was mostly spherical in shape. The average size of NPs was about 140 nm with EE ranged in 94% -98% and zeta potential of -21.7 ± 4.3 mV. CONCLUSION Optimized preparation parameters led to nanoparticles with well - defined characteristics such as high EE and might be used to prepare a series of drug loaded triblock copolymeric nanoparticles for drug delivery system of intravenous injection.
出处 《华西药学杂志》 CAS CSCD 北大核心 2006年第4期321-324,共4页 West China Journal of Pharmaceutical Sciences
基金 国家科技部"十五"攻关项目(批准号:004AA273142)
关键词 三嵌段共聚物 纳米粒 胰岛素 包封率 Triblock copolymer Nanoparticles Insulin Encapsulation efficiency
  • 相关文献

参考文献12

  • 1Young Jin Kim, Suna Choi ,Jae Joon Koh, et al. Controlled release of Insulin from injectable biodegradable triblock copolymer[ J ].Pharmaceutical Research,2001,18 ( 4 ) : 548 - 550.
  • 2Bilati U ,All,mann E, Doelker E. Poly( D, L - lactide - co - glycolide) protein- loaded nanoparticles prepared by the double emulsion method - processing and formulation issues for enhanced entrapment efficiency [ J ]. J Microencapsulation, 2005,22 ( 2 ) :205 - 214.
  • 3Kumaresh S Soppimath ,Tejraj M Aminabhavi, Anandrao R Kulkami ,et al Biodegradable polymeric nanoparticles as drug delivery devices [ J ]. J Controlled Release ,2001,70 : 1 - 20.
  • 4Duan YR,Zhang ZR,Huang Y,et al. Preparation of Nano - HAP as vectors for targeting delivery system [ J ]. Key Engineering Materials ,2004,254 - 256,887 - 890.
  • 5Sun X, Duan YR, Zhang ZR, et al. PELGE nanoparticles as new carriers for the delivery of plasmid DNA [ J ]. Chem & Pharm Bulletin ,2005,53 (6) :599 - 603.
  • 6陈蜀,张志荣,段友容,石海涛.阿柔比星A PELGE纳米粒的制备及质量评价[J].中国抗生素杂志,2005,30(11):659-661. 被引量:1
  • 7Blanco MD, Alonso MJ. Development and characterization of protein - loaded poly ( lactide - co - glycolide ) nanospheres [ J ].Eur J Pharmac Biopharm, 1997,43 (3) :287 - 294.
  • 8Xu Xiongliang, Fu Yao, Zhang Zhirong, et al. Quantitative determination of Insulin entrapment efficiency in triblock copolymeric nanoparticles by high - performance liquid chromatography [ J ]. J Pharm Biom Anal,2006,41 (1) :266- 273.
  • 9Rosa G De,Iommelli R,Rotonda MI La,et al. Influence of the coencapsulation of different non - ionic sudactants on the properties of PLGA Insulin - loaded microspheres [ J ]. J Controlled Release ,2000,69:283 - 295.
  • 10Wolf M, Wirth M, Pittner F, et al. Stabilisation and determination of the biological activity of 1 - asparaginase in poly( d,1 - lactide -co - glycolide) nanospheres [ J ]. Int J Pharm ,2003,256 : 141 -152.

二级参考文献8

  • 1Soppimath K S, Aminabhavi T M, Kulkarni A R, et al.Biodegradable polymeric nanoparticles as drug delivery devices [J]. J Controlled Rel,2001,70(1) :1.
  • 2Kumar N, Ravikumar M N V, Domb A J, et al.Biodegradable block copolymers [J]. Adv Drug Deliv Rev, 2001,53 : 23.
  • 3Bures P, Huang Y, Oral E, et al. Surface modifications of molecular imprinting of polymers in medical and pharmaceutical applications [J]. J Control Rel, 2001,72 (1 ~ 3):25.
  • 4Duan Y R, Zhang Y, Gong T, et al. Synthesis, characterization of PELGE as drug carrier and their degradation behaviour in vitro [J]. J Mater Sci Lett,in press.
  • 5Govender T, Stolnik S, Garnett M C, et al. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug [J]. J controlled Rel, 1999,57:171.
  • 6Avgoustakis K, Beletsi A, Panagi Z, et al. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties [J]. J Controlled Rel, 2002,79:123.
  • 7Junko M, Yuichiro N, Kazuo S. Preparation of nanopartitles consist of poly (lqactide)-poly (ethylene glycol)-poly (l-lactied) and their evaluation in vitro [J]. Int J Pharm,1999,185:93.
  • 8蒋学华,何林.阿柔比星A聚乳酸毫微粒冻干针剂的研制及体外药物释放规律的研究[J].中国抗生素杂志,2000,25(5):359-361. 被引量:3

同被引文献70

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部